|
OPA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.65378863118349E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28329577467434E-11 |
| Normal-vs-Stage2 |
4.24720000000711E-05 |
| Normal-vs-Stage3 |
5.79169999959106E-07 |
| Normal-vs-Stage4 |
4.94000396145111E-11 |
| Stage1-vs-Stage2 |
9.226800E-01 |
| Stage1-vs-Stage3 |
4.639400E-01 |
| Stage1-vs-Stage4 |
6.443700E-04 |
| Stage2-vs-Stage3 |
6.580200E-01 |
| Stage2-vs-Stage4 |
1.155840E-02 |
| Stage3-vs-Stage4 |
2.670400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83686399424232E-12 |
| Normal-vs-AfricanAmerican |
3.76459999840151E-08 |
| Normal-vs-Asian |
1.175630E-01 |
| Caucasian-vs-AfricanAmerican |
2.981200E-01 |
| Caucasian-vs-Asian |
8.390200E-01 |
| AfricanAmerican-vs-Asian |
5.266800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.86690679476942E-13 |
| Normal-vs-Female |
1.54123999999145E-05 |
| Male-vs-Female |
1.015580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.02500000393513E-08 |
| Normal-vs-Extreme_Weight |
2.60902410786912E-14 |
| Normal-vs-Obese |
1.8855999994738E-07 |
| Normal-vs-Extreme_Obese |
9.756400E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.588400E-01 |
| Normal_Weight-vs-Obese |
2.683800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.248800E-01 |
| Extreme_Weight-vs-Obese |
6.821700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.903550E-01 |
| Obese-vs-Extreme_Obese |
8.865400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.599390E-03 |
| Normal-vs-Age(41-60Yrs) |
1.05249997606194E-09 |
| Normal-vs-Age(61-80Yrs) |
7.73825448163734E-13 |
| Normal-vs-Age(81-100Yrs) |
2.6338999981057E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.469200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.512600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.771800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.705700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.248000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.155000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.61193322315512E-12 |
| Normal-VS-Type2 PRCC |
3.28700000551407E-09 |
| Normal-VS-KIRP CIMP |
6.00470007050546E-10 |
| Normal-VS-Unclassified PRCC |
1.220090E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.026800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.139600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.506820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.520500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.280000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.451950E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45969999923545E-09 |
| Normal-vs-N1 |
1.05120356863608E-11 |
| Normal-vs-N2 |
2.06089999998937E-06 |
| N0-vs-N1 |
3.654800E-01 |
| N0-vs-N2 |
2.925800E-01 |
| N1-vs-N2 |
2.412400E-01 |
|
|
